Experimental data derived from cell transfection and animal model experiments demonstrated that overexpression of wild-type or mutant PCSK9 induces a marked reduction in hepatic LDLR protein and hypercholesterolemia [22,43,54]. This evidence concerns the gene LDLR and Hypercholesterolemia.